Yemi Adesokan is Chief Scientific Officer and Co-Founder at Gnubiotics SA,  a Lausanne, Switzerland biotech company pioneering the development of Human Milk Oligosacchrides (HMOs) for infants and adults as well as Animal Milk Oligosaccharides (AMOs) for companion animals.  Yemi has been recognized for his innovative and pioneering work with awards such as the Boston Business Journal 40 under 40 award and the  MIT Technology Review’s annual list of 35 top global innovators under the age of 35 TR35. Yemi has a PhD in Chemistry from the University of California, Irvine and completed a post-doctoral fellowship in Genetics with George Church at Harvard Medical School.